SCHEMBL20060131

SCHEMBL20060131

COC(=O)C(Cc1ccccc1)c1ccccc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
POLB P06746 1/20 0.48
ATM Q13315 2/20 0.47
ALDH1A1 P00352 2/20 0.46
THRB P10828 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MMP8 P22894 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
RAB9A P51151 2/20 0.44
GAA P10253 1/20 0.44
CHRM1 P11229 1/20 0.43
NPC1 O15118 1/20 0.43
CA12 O43570 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29794302 0.84 CYP2C19 (0.52) ESR1ESR2POLBATMALDH1A1
SCHEMBL468137 0.84 CYP2C19 (0.52) ESR1ESR2POLBATMALDH1A1
SCHEMBL30910849 0.82 KMT2A (0.42) ESR1ALDH1A1KMT2AGAA
SCHEMBL15910867 0.82 KMT2A (0.42) ESR1ESR2ALDH1A1THRBCYP2C9
SCHEMBL1928826 0.82 KMT2A (0.42) ESR1ALDH1A1KMT2AGAA
SCHEMBL684343 0.82 ATM (0.48) ESR1ESR2POLBATMALDH1A1
SCHEMBL14678497 0.81 EPHX1 (0.62) POLBALDH1A1CYP2C9CYP2C19HSD17B10
SCHEMBL1234209 0.80 ESR1 (0.68) ESR1ESR2POLBATMALDH1A1
SCHEMBL14874462 0.76 MMP8 (0.50) POLBALDH1A1CYP2C19MMP8L3MBTL1
SCHEMBL27887848 0.76 TDP1 (0.52) ATMALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4101297-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Pharmaceuticals, Inc. (US) 2022-12-14 EP disclosed
EP-3607821-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Therapeutics, Inc. (US) 2020-02-12 EP disclosed
EP-2451279-B1 BENZOSULFONAMIDE DERIVATIVES, COMPOSITIONS THEREOF, AND THEIR USE IN PREVENTING METASTASIS OF CANCER CELLS AERPIO THERAPEUTICS INC (US) 2019-03-13 EP disclosed
EP-2385763-B1 METHODS FOR TREATING VASCULAR LEAK SYNDROME AERPIO THERAPEUTICS INC (US) 2018-04-18 EP disclosed